DCAKD抗体DCAKD兔多抗抗体DCAKDDephosph
o-CoA kinase domain-containing protein antibody抗体DCAKD Antibody抗体- ￥440 - 1320
- CUSABIO
- CN
- CSB-PA855481LA01HU
- 2025年07月09日
- ELISA
- Rabbit
- Human
企业认证
相关产品推荐更多 >
CCM2抗体CCM2兔多抗抗体PP10187 antibody抗体CCM2 Antibody抗体
￥440
ATP5S抗体ATP5S一抗抗体Mitochondrial ATP synthase regulatory component factor B antibody抗体ATP5S Antibody抗体
￥880
ANKRD49抗体ANKRD49兔多抗抗体Fetal globin-inducing factor antibody抗体ANKRD49 Antibody抗体
￥440
ARHGEF2抗体ARHGEF2一抗抗体rho/rac guanine nucleotide exchange factor antibody抗体Phospho-ARHGEF2 (S885) Antibody抗体
￥880
VPS50抗体VPS50兔多抗抗体EARP/GARPII complex subunit VPS50 antibody抗体VPS50 Antibody, HRP conjugated抗体
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human Dephospho-CoA kinase domain-containing protein (1-231AA)
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
Polyclonal
- 标记物：
Non-conjugated
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
Q8WVC6
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA
- 浓度：
>95%,Protein G purified
- 靶点：
DCAKD
- 抗体英文名：
DCAKD Antibody
- 抗体名：
DCAKDDephospho-CoA kinase domain-containing protein antibody
- 规格：
100μg/50μg/20μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
| 规格： | 20μg | 产品价格： | ￥440.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
功能
membrane, dephospho-CoA kinase activity, coenzyme A biosynthetic process, phosphorylation风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验【信息】The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
-like receptor) signal transduction involves five adaptor proteins. MyD88 (myeloid differentiation primary-response gene 88), MAL (MyD88-adaptor-like protein), TRIF (TIR-domain-containing adaptor protein inducing interferon- (IFN)) and TRAM (TRIF-related adaptor
Polo-like kinase 1 (Plk1) is a key player in mitosis and has been widely recognized as a therapeutic target for many human cancer types. Apart from its kinase domain, Plk1 harbors a protein–protein interaction domain dubbed “polo-box domain
(BCR) in vitro suggest a vital role of LMP2A in the maintenance of EBV latency. Studies of LMP2A have shown that specific sequences of the amino-terminal domain interact with multiple cellular proteins, downmodulate cellular protein tyrosine
技术资料暂无技术资料 索取技术资料
